Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) has issued an announcement.
Recordati S.p.A. announced the resignation of Dr. Livia Amidani Aliberti as Actual Auditor, effective immediately, due to personal reasons. Dr. Silvia Mina, previously an Alternate Auditor, will assume the role of Actual Auditor until the next Shareholders’ Meeting. This change is in accordance with the company’s Articles of Association and does not impact the company’s shareholding structure as neither auditor holds shares in the company.
The most recent analyst rating on (IT:REC) stock is a Hold with a EUR51.00 price target. To see the full list of analyst forecasts on Recordati Industria Chimica e Farmaceutica SPA stock, see the IT:REC Stock Forecast page.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati is an international pharmaceutical group listed on the Italian Stock Exchange, originating from a family-run pharmacy in Northern Italy in the 1920s. The company offers therapeutic options in general and specialist medicine, as well as for rare diseases, and operates in a fully integrated manner from clinical development to production, marketing, and licensing. Recordati is present in about 150 countries across the EMEA, Americas, and APAC regions, employing over 4,580 people worldwide.
YTD Price Performance: 1.52%
Average Trading Volume: 288,714
Technical Sentiment Signal: Buy
Current Market Cap: €10.46B
For a thorough assessment of REC stock, go to TipRanks’ Stock Analysis page.